

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.67826989 |
| 2 | negative regulation of cell killing (GO:0031342) | 4.67826989 |
| 3 | response to peptidoglycan (GO:0032494) | 4.14687241 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 3.85214347 |
| 5 | immunoglobulin mediated immune response (GO:0016064) | 3.70542578 |
| 6 | detection of other organism (GO:0098543) | 3.67000755 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.58636066 |
| 8 | cellular extravasation (GO:0045123) | 3.52500771 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.47785895 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.47785895 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 3.47785895 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 3.47785895 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 3.47785895 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.47785895 |
| 15 | detection of bacterium (GO:0016045) | 3.47057925 |
| 16 | cellular response to type I interferon (GO:0071357) | 3.46081427 |
| 17 | type I interferon signaling pathway (GO:0060337) | 3.46081427 |
| 18 | response to type I interferon (GO:0034340) | 3.43338116 |
| 19 | germinal center formation (GO:0002467) | 3.39832162 |
| 20 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.38283136 |
| 21 | cell adhesion mediated by integrin (GO:0033627) | 3.37629235 |
| 22 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.32129054 |
| 23 | detection of molecule of bacterial origin (GO:0032490) | 3.29944710 |
| 24 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.29268115 |
| 25 | apoptotic cell clearance (GO:0043277) | 3.27934571 |
| 26 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.26526687 |
| 27 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.26526687 |
| 28 | detection of external biotic stimulus (GO:0098581) | 3.22156432 |
| 29 | neutrophil activation (GO:0042119) | 3.13926895 |
| 30 | positive regulation of p38MAPK cascade (GO:1900745) | 3.12853570 |
| 31 | granulocyte activation (GO:0036230) | 3.11365013 |
| 32 | defense response to protozoan (GO:0042832) | 3.08971389 |
| 33 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.08422287 |
| 34 | leukocyte aggregation (GO:0070486) | 3.04914432 |
| 35 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.01662310 |
| 36 | macrophage activation (GO:0042116) | 3.00388692 |
| 37 | T-helper 1 type immune response (GO:0042088) | 2.99509476 |
| 38 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.98874749 |
| 39 | hemidesmosome assembly (GO:0031581) | 2.98863700 |
| 40 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.98091953 |
| 41 | response to protozoan (GO:0001562) | 2.94689965 |
| 42 | regulation of T cell tolerance induction (GO:0002664) | 2.94211754 |
| 43 | myeloid cell activation involved in immune response (GO:0002275) | 2.94058372 |
| 44 | low-density lipoprotein particle clearance (GO:0034383) | 2.93161642 |
| 45 | negative regulation of T cell mediated immunity (GO:0002710) | 2.92712821 |
| 46 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.91698466 |
| 47 | growth hormone receptor signaling pathway (GO:0060396) | 2.90156465 |
| 48 | microglial cell activation (GO:0001774) | 2.90087686 |
| 49 | regulation of cholesterol storage (GO:0010885) | 2.88649825 |
| 50 | response to interleukin-15 (GO:0070672) | 2.88401405 |
| 51 | regulation of tolerance induction (GO:0002643) | 2.86227357 |
| 52 | detection of biotic stimulus (GO:0009595) | 2.84492637 |
| 53 | tolerance induction (GO:0002507) | 2.84487418 |
| 54 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.83791635 |
| 55 | regulation of cholesterol homeostasis (GO:2000188) | 2.80068374 |
| 56 | protein localization to endosome (GO:0036010) | 2.79054736 |
| 57 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.79043534 |
| 58 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.77802012 |
| 59 | regulation of mast cell degranulation (GO:0043304) | 2.77088576 |
| 60 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.74161637 |
| 61 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.73877978 |
| 62 | response to laminar fluid shear stress (GO:0034616) | 2.73690002 |
| 63 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.73551308 |
| 64 | B cell mediated immunity (GO:0019724) | 2.72278481 |
| 65 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.71841420 |
| 66 | positive regulation of type 2 immune response (GO:0002830) | 2.71163636 |
| 67 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.71081106 |
| 68 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.69099814 |
| 69 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.68592299 |
| 70 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.67986386 |
| 71 | NIK/NF-kappaB signaling (GO:0038061) | 2.67898105 |
| 72 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.67804177 |
| 73 | cellular response to interleukin-15 (GO:0071350) | 2.67624603 |
| 74 | macrophage activation involved in immune response (GO:0002281) | 2.67393559 |
| 75 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.67218449 |
| 76 | regulation of antigen processing and presentation (GO:0002577) | 2.66164686 |
| 77 | positive regulation of histone deacetylation (GO:0031065) | 2.65895126 |
| 78 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.65767952 |
| 79 | negative regulation of innate immune response (GO:0045824) | 2.65019523 |
| 80 | negative regulation of interleukin-6 production (GO:0032715) | 2.64503193 |
| 81 | regulation of p38MAPK cascade (GO:1900744) | 2.62143876 |
| 82 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.59359380 |
| 83 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.59359380 |
| 84 | positive regulation of tolerance induction (GO:0002645) | 2.59301406 |
| 85 | positive regulation of antigen processing and presentation (GO:0002579) | 2.58605234 |
| 86 | plasma membrane repair (GO:0001778) | 2.58472188 |
| 87 | myeloid dendritic cell differentiation (GO:0043011) | 2.58082442 |
| 88 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.57719265 |
| 89 | T cell migration (GO:0072678) | 2.56505138 |
| 90 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.55665043 |
| 91 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.55555852 |
| 92 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.55316832 |
| 93 | regulation of mast cell activation (GO:0033003) | 2.54437679 |
| 94 | negative regulation of fatty acid transport (GO:2000192) | 2.53157917 |
| 95 | positive regulation of mast cell activation (GO:0033005) | 2.53131271 |
| 96 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.52097737 |
| 97 | regulation of regulatory T cell differentiation (GO:0045589) | 2.51762453 |
| 98 | B cell receptor signaling pathway (GO:0050853) | 2.50900577 |
| 99 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.50363586 |
| 100 | positive regulation of interferon-alpha production (GO:0032727) | 2.50235674 |
| 101 | regulation of interleukin-12 production (GO:0032655) | 2.50028948 |
| 102 | respiratory burst (GO:0045730) | 2.49550623 |
| 103 | endodermal cell differentiation (GO:0035987) | 2.49539892 |
| 104 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.48787715 |
| 105 | skin morphogenesis (GO:0043589) | 2.47988433 |
| 106 | cellular response to interferon-gamma (GO:0071346) | 2.47579202 |
| 107 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.47525479 |
| 108 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.47384138 |
| 109 | cellular response to growth hormone stimulus (GO:0071378) | 2.46630444 |
| 110 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.45235587 |
| 111 | cell-substrate junction assembly (GO:0007044) | 2.42859529 |
| 112 | regulation of interferon-alpha production (GO:0032647) | 2.40580362 |
| 113 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.39290820 |
| 114 | epithelial cell-cell adhesion (GO:0090136) | 2.38800332 |
| 115 | regulation of gamma-delta T cell activation (GO:0046643) | 2.33905018 |
| 116 | positive regulation of lipid storage (GO:0010884) | 2.32629145 |
| 117 | adhesion of symbiont to host cell (GO:0044650) | 2.29287640 |
| 118 | virion attachment to host cell (GO:0019062) | 2.29287640 |
| 119 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.29277642 |
| 120 | response to host (GO:0075136) | 2.29277642 |
| 121 | response to host defenses (GO:0052200) | 2.29277642 |
| 122 | basement membrane organization (GO:0071711) | 2.28986549 |
| 123 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.25038818 |
| 124 | response to host immune response (GO:0052572) | 2.24781397 |
| 125 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.24781397 |
| 126 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.23615200 |
| 127 | regulation of podosome assembly (GO:0071801) | 2.21781278 |
| 128 | cellular response to interferon-alpha (GO:0035457) | 2.21315011 |
| 129 | adhesion of symbiont to host (GO:0044406) | 2.20502045 |
| 130 | regulation of macrophage cytokine production (GO:0010935) | 2.19255888 |
| 131 | establishment of endothelial barrier (GO:0061028) | 2.17724291 |
| 132 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.14169140 |
| 133 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.13908954 |
| 134 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.13234022 |
| 135 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.12478701 |
| 136 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.12381954 |
| 137 | response to fluid shear stress (GO:0034405) | 2.12267833 |
| 138 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.12009046 |
| 139 | lysine metabolic process (GO:0006553) | 2.11131913 |
| 140 | lysine catabolic process (GO:0006554) | 2.11131913 |
| 141 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.10627946 |
| 142 | I-kappaB phosphorylation (GO:0007252) | 2.10444382 |
| 143 | response to muramyl dipeptide (GO:0032495) | 2.10329663 |
| 144 | wound healing, spreading of epidermal cells (GO:0035313) | 2.09009426 |
| 145 | protein carboxylation (GO:0018214) | 2.08564475 |
| 146 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.08564475 |
| 147 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.06373777 |
| 148 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.05883482 |
| 149 | positive regulation of macrophage cytokine production (GO:0060907) | 2.04040681 |
| 150 | negative regulation of lipid transport (GO:0032369) | 2.03830181 |
| 151 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.03595157 |
| 152 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.03583429 |
| 153 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.02696498 |
| 154 | stress fiber assembly (GO:0043149) | 2.01919453 |
| 155 | regulation of integrin activation (GO:0033623) | 2.01617779 |
| 156 | blood vessel endothelial cell migration (GO:0043534) | 2.00596347 |
| 157 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 1.99928348 |
| 158 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 1.99852975 |
| 159 | negative regulation of lipid storage (GO:0010888) | 1.99796574 |
| 160 | negative regulation of interleukin-12 production (GO:0032695) | 1.99081870 |
| 161 | desmosome organization (GO:0002934) | 1.97723726 |
| 162 | response to growth hormone (GO:0060416) | 1.97544497 |
| 163 | endothelial cell chemotaxis (GO:0035767) | 1.97284401 |
| 164 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 1.97252796 |
| 165 | plasma lipoprotein particle clearance (GO:0034381) | 1.96075855 |
| 166 | substrate-dependent cell migration (GO:0006929) | 1.95737719 |
| 167 | positive thymic T cell selection (GO:0045059) | 1.95485491 |
| 168 | 4-hydroxyproline metabolic process (GO:0019471) | 1.95077731 |
| 169 | phospholipid homeostasis (GO:0055091) | 1.94701508 |
| 170 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 1.93871347 |
| 171 | positive regulation of reactive oxygen species metabolic process (GO:2000379) | 1.93191844 |
| 172 | pinocytosis (GO:0006907) | 1.92761566 |
| 173 | regulation of fatty acid beta-oxidation (GO:0031998) | 1.92234917 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.22072232 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.59120159 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.88754416 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.71587611 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.66464897 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.57601528 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.54951085 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.49000632 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.47145538 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.46662447 |
| 11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.37162878 |
| 12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.32236741 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.29181731 |
| 14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.25529326 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.25250051 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.25015156 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.21140385 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.21108715 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.19282124 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.13028895 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.11522130 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.08264250 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.95909968 |
| 24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.93836681 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93112811 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.91533496 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.89723697 |
| 28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.89496114 |
| 29 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.88959270 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.86647954 |
| 31 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.84591694 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.81489801 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77919841 |
| 34 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.77619321 |
| 35 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.76594734 |
| 36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.76464153 |
| 37 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.74981980 |
| 38 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.69445781 |
| 39 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.67795559 |
| 40 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.66961812 |
| 41 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63906108 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.58875485 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.57298927 |
| 44 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.57285112 |
| 45 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.55385640 |
| 46 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54530298 |
| 47 | MYB_26560356_Chip-Seq_TH1_Human | 1.54037036 |
| 48 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.53297058 |
| 49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.52006514 |
| 50 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.51844338 |
| 51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.51436167 |
| 52 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.50542926 |
| 53 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.49375389 |
| 54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.48910787 |
| 55 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48671261 |
| 56 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.48097270 |
| 57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.45504478 |
| 58 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.44785067 |
| 59 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.42903548 |
| 60 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42837346 |
| 61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40063328 |
| 62 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.38773738 |
| 63 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.38676237 |
| 64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38458959 |
| 65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.37709747 |
| 66 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37009466 |
| 67 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.35130507 |
| 68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33647614 |
| 69 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.31430093 |
| 70 | MAF_26560356_Chip-Seq_TH1_Human | 1.31073315 |
| 71 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.28461640 |
| 72 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.28438173 |
| 73 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27008514 |
| 74 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.26979447 |
| 75 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.26979447 |
| 76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.26035264 |
| 77 | ATF3_27146783_Chip-Seq_COLON_Human | 1.25881941 |
| 78 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25763262 |
| 79 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.25561990 |
| 80 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.25330227 |
| 81 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.24895120 |
| 82 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.24828443 |
| 83 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.24798839 |
| 84 | GATA3_26560356_Chip-Seq_TH2_Human | 1.24602342 |
| 85 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.24128438 |
| 86 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.23301902 |
| 87 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.23301902 |
| 88 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22581211 |
| 89 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22504144 |
| 90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22030385 |
| 91 | SPI1_23127762_ChIP-Seq_K562_Human | 1.18815875 |
| 92 | CJUN_26792858_Chip-Seq_BT549_Human | 1.17559082 |
| 93 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17542204 |
| 94 | GATA1_22025678_ChIP-Seq_K562_Human | 1.17332305 |
| 95 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.14864510 |
| 96 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.11682254 |
| 97 | MYC_22102868_ChIP-Seq_BL_Human | 1.11444427 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 1.10857430 |
| 99 | KDM2B_26808549_Chip-Seq_K562_Human | 1.10149416 |
| 100 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.10036213 |
| 101 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09193826 |
| 102 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.07326572 |
| 103 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.07245769 |
| 104 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06934942 |
| 105 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06244771 |
| 106 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.06130829 |
| 107 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04863416 |
| 108 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04538792 |
| 109 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.04275721 |
| 110 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04052263 |
| 111 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04043201 |
| 112 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.03119934 |
| 113 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02523376 |
| 114 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00149641 |
| 115 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.99328079 |
| 116 | MYB_26560356_Chip-Seq_TH2_Human | 0.98945376 |
| 117 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.98649884 |
| 118 | UTX_26944678_Chip-Seq_JUKART_Human | 0.98464367 |
| 119 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98059993 |
| 120 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.97997012 |
| 121 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.97514720 |
| 122 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97011541 |
| 123 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96811972 |
| 124 | MAF_26560356_Chip-Seq_TH2_Human | 0.95475003 |
| 125 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95406332 |
| 126 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.93235860 |
| 127 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93079609 |
| 128 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93028370 |
| 129 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92861114 |
| 130 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92808546 |
| 131 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92317108 |
| 132 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92234929 |
| 133 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90984923 |
| 134 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90223514 |
| 135 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.87136130 |
| 136 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85219228 |
| 137 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83798208 |
| 138 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.80283165 |
| 139 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.77347077 |
| 140 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.74227731 |
| 141 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.74195887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 3.48128088 |
| 2 | MP0003300_gastrointestinal_ulcer | 2.95220103 |
| 3 | MP0005671_abnormal_response_to | 2.83742153 |
| 4 | MP0003303_peritoneal_inflammation | 2.58228894 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 2.51688612 |
| 6 | MP0003566_abnormal_cell_adhesion | 2.30464060 |
| 7 | MP0009840_abnormal_foam_cell | 2.24709826 |
| 8 | MP0010352_gastrointestinal_tract_polyps | 2.12620311 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.09933151 |
| 10 | MP0002420_abnormal_adaptive_immunity | 2.09561149 |
| 11 | MP0001819_abnormal_immune_cell | 2.08407836 |
| 12 | MP0003436_decreased_susceptibility_to | 2.02849883 |
| 13 | MP0005275_abnormal_skin_tensile | 2.01783851 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 1.99947557 |
| 15 | MP0004510_myositis | 1.97260663 |
| 16 | MP0004947_skin_inflammation | 1.84943402 |
| 17 | MP0003763_abnormal_thymus_physiology | 1.76984903 |
| 18 | MP0005360_urolithiasis | 1.76198777 |
| 19 | MP0003045_fibrosis | 1.75203768 |
| 20 | MP0005058_abnormal_lysosome_morphology | 1.72303588 |
| 21 | MP0001958_emphysema | 1.68489367 |
| 22 | MP0005076_abnormal_cell_differentiation | 1.67610154 |
| 23 | MP0005023_abnormal_wound_healing | 1.65026775 |
| 24 | MP0000685_abnormal_immune_system | 1.63593374 |
| 25 | MP0003453_abnormal_keratinocyte_physiol | 1.58986732 |
| 26 | MP0002254_reproductive_system_inflammat | 1.55294567 |
| 27 | MP0005310_abnormal_salivary_gland | 1.54007411 |
| 28 | MP0009278_abnormal_bone_marrow | 1.53220837 |
| 29 | MP0000716_abnormal_immune_system | 1.53177296 |
| 30 | MP0006082_CNS_inflammation | 1.49516076 |
| 31 | MP0003279_aneurysm | 1.47793136 |
| 32 | MP0003091_abnormal_cell_migration | 1.47320338 |
| 33 | MP0001790_abnormal_immune_system | 1.47115697 |
| 34 | MP0005387_immune_system_phenotype | 1.47115697 |
| 35 | MP0003183_abnormal_peptide_metabolism | 1.47103020 |
| 36 | MP0000343_altered_response_to | 1.46186462 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.45740824 |
| 38 | MP0009785_altered_susceptibility_to | 1.43887962 |
| 39 | MP0003724_increased_susceptibility_to | 1.42713237 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.42460179 |
| 41 | MP0002398_abnormal_bone_marrow | 1.40784480 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.39779559 |
| 43 | MP0002139_abnormal_hepatobiliary_system | 1.36872944 |
| 44 | MP0003866_abnormal_defecation | 1.36743558 |
| 45 | MP0001835_abnormal_antigen_presentation | 1.35752934 |
| 46 | MP0004272_abnormal_basement_membrane | 1.33967437 |
| 47 | MP0002419_abnormal_innate_immunity | 1.31236758 |
| 48 | MP0003448_altered_tumor_morphology | 1.30739113 |
| 49 | MP0002877_abnormal_melanocyte_morpholog | 1.29130581 |
| 50 | MP0000604_amyloidosis | 1.28164568 |
| 51 | MP0008004_abnormal_stomach_pH | 1.27391723 |
| 52 | MP0004858_abnormal_nervous_system | 1.26764576 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.26515459 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.26515459 |
| 55 | MP0005451_abnormal_body_composition | 1.26228815 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.26220205 |
| 57 | MP0005000_abnormal_immune_tolerance | 1.26166805 |
| 58 | MP0000733_abnormal_muscle_development | 1.25941913 |
| 59 | MP0005083_abnormal_biliary_tract | 1.24732473 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.23541172 |
| 61 | MP0003195_calcinosis | 1.22580057 |
| 62 | MP0004084_abnormal_cardiac_muscle | 1.22425517 |
| 63 | MP0002060_abnormal_skin_morphology | 1.21311840 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.20674916 |
| 65 | MP0003252_abnormal_bile_duct | 1.20593131 |
| 66 | MP0004130_abnormal_muscle_cell | 1.20430390 |
| 67 | MP0002998_abnormal_bone_remodeling | 1.17457302 |
| 68 | MP0003075_altered_response_to | 1.17382314 |
| 69 | MP0003828_pulmonary_edema | 1.16783829 |
| 70 | MP0005025_abnormal_response_to | 1.16312457 |
| 71 | MP0000858_altered_metastatic_potential | 1.16179661 |
| 72 | MP0008961_abnormal_basal_metabolism | 1.14972053 |
| 73 | MP0002138_abnormal_hepatobiliary_system | 1.13636574 |
| 74 | MP0002429_abnormal_blood_cell | 1.13521666 |
| 75 | MP0009764_decreased_sensitivity_to | 1.12110543 |
| 76 | MP0002722_abnormal_immune_system | 1.11202745 |
| 77 | MP0001849_ear_inflammation | 1.10617352 |
| 78 | MP0004883_abnormal_blood_vessel | 1.10125631 |
| 79 | MP0003690_abnormal_glial_cell | 1.09715653 |
| 80 | MP0003172_abnormal_lysosome_physiology | 1.08797599 |
| 81 | MP0002796_impaired_skin_barrier | 1.08609170 |
| 82 | MP0005167_abnormal_blood-brain_barrier | 1.07900875 |
| 83 | MP0003656_abnormal_erythrocyte_physiolo | 1.06752531 |
| 84 | MP0000609_abnormal_liver_physiology | 1.04820266 |
| 85 | MP0005464_abnormal_platelet_physiology | 1.03630830 |
| 86 | MP0000750_abnormal_muscle_regeneration | 1.03330386 |
| 87 | MP0001845_abnormal_inflammatory_respons | 1.03055046 |
| 88 | MP0001851_eye_inflammation | 1.02712172 |
| 89 | MP0002168_other_aberrant_phenotype | 1.02609645 |
| 90 | MP0002405_respiratory_system_inflammati | 1.02132067 |
| 91 | MP0002277_abnormal_respiratory_mucosa | 1.01533682 |
| 92 | MP0005166_decreased_susceptibility_to | 1.00808734 |
| 93 | MP0008260_abnormal_autophagy | 1.00267171 |
| 94 | MP0002006_tumorigenesis | 1.00235672 |
| 95 | MP0002452_abnormal_antigen_presenting | 1.00036435 |
| 96 | MP0001853_heart_inflammation | 1.00013341 |
| 97 | MP0004185_abnormal_adipocyte_glucose | 0.99578610 |
| 98 | MP0002148_abnormal_hypersensitivity_rea | 0.99190845 |
| 99 | MP0004087_abnormal_muscle_fiber | 0.99013241 |
| 100 | MP0001800_abnormal_humoral_immune | 0.97876283 |
| 101 | MP0010630_abnormal_cardiac_muscle | 0.94954697 |
| 102 | MP0002132_abnormal_respiratory_system | 0.92427524 |
| 103 | MP0010329_abnormal_lipoprotein_level | 0.92361917 |
| 104 | MP0000767_abnormal_smooth_muscle | 0.92278732 |
| 105 | MP0008469_abnormal_protein_level | 0.91739062 |
| 106 | MP0006054_spinal_hemorrhage | 0.90354709 |
| 107 | MP0009643_abnormal_urine_homeostasis | 0.90225546 |
| 108 | MP0002723_abnormal_immune_serum | 0.90206255 |
| 109 | MP0001873_stomach_inflammation | 0.90087063 |
| 110 | MP0010368_abnormal_lymphatic_system | 0.90056932 |
| 111 | MP0002933_joint_inflammation | 0.89125790 |
| 112 | MP0002332_abnormal_exercise_endurance | 0.89027771 |
| 113 | MP0005666_abnormal_adipose_tissue | 0.88566365 |
| 114 | MP0009384_cardiac_valve_regurgitation | 0.88393547 |
| 115 | MP0002136_abnormal_kidney_physiology | 0.84815388 |
| 116 | MP0000249_abnormal_blood_vessel | 0.83951880 |
| 117 | MP0005623_abnormal_meninges_morphology | 0.83789413 |
| 118 | MP0005390_skeleton_phenotype | 0.83527400 |
| 119 | MP0009763_increased_sensitivity_to | 0.82957234 |
| 120 | MP0000751_myopathy | 0.82784502 |
| 121 | MP0005085_abnormal_gallbladder_physiolo | 0.82637842 |
| 122 | MP0005365_abnormal_bile_salt | 0.82494664 |
| 123 | MP0002837_dystrophic_cardiac_calcinosis | 0.82305513 |
| 124 | MP0005165_increased_susceptibility_to | 0.81942225 |
| 125 | MP0000703_abnormal_thymus_morphology | 0.81899756 |
| 126 | MP0004381_abnormal_hair_follicle | 0.81875260 |
| 127 | MP0005164_abnormal_response_to | 0.81343620 |
| 128 | MP0008875_abnormal_xenobiotic_pharmacok | 0.80772401 |
| 129 | MP0010307_abnormal_tumor_latency | 0.80623528 |
| 130 | MP0005319_abnormal_enzyme/_coenzyme | 0.80474884 |
| 131 | MP0001663_abnormal_digestive_system | 0.79180857 |
| 132 | MP0002693_abnormal_pancreas_physiology | 0.78469093 |
| 133 | MP0001881_abnormal_mammary_gland | 0.76883517 |
| 134 | MP0003795_abnormal_bone_structure | 0.76594885 |
| 135 | MP0005535_abnormal_body_temperature | 0.67937173 |
| 136 | MP0009765_abnormal_xenobiotic_induced | 0.67718536 |
| 137 | MP0001501_abnormal_sleep_pattern | 0.66374285 |
| 138 | MP0008874_decreased_physiological_sensi | 0.60635075 |
| 139 | MP0000920_abnormal_myelination | 0.60075539 |
| 140 | MP0004808_abnormal_hematopoietic_stem | 0.57860284 |
| 141 | MP0000015_abnormal_ear_pigmentation | 0.57553983 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Retrobulbar optic neuritis (HP:0100654) | 4.68624431 |
| 2 | Optic neuritis (HP:0100653) | 4.68624431 |
| 3 | Stomatitis (HP:0010280) | 4.57132648 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.21228765 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.21228765 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.21228765 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 3.59123032 |
| 8 | Recurrent fungal infections (HP:0002841) | 3.41139580 |
| 9 | Vasculitis (HP:0002633) | 3.38794621 |
| 10 | Eczematoid dermatitis (HP:0000976) | 3.35847358 |
| 11 | Right ventricular cardiomyopathy (HP:0011663) | 3.30726832 |
| 12 | Keratoconjunctivitis sicca (HP:0001097) | 3.25738849 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 3.25715767 |
| 14 | Recurrent skin infections (HP:0001581) | 3.19974125 |
| 15 | Pulmonary infiltrates (HP:0002113) | 3.19517658 |
| 16 | Cerebral aneurysm (HP:0004944) | 3.17890886 |
| 17 | Hemoptysis (HP:0002105) | 3.08788294 |
| 18 | Keratoconjunctivitis (HP:0001096) | 3.07981529 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.06759095 |
| 20 | Meningitis (HP:0001287) | 3.06379268 |
| 21 | Protrusio acetabuli (HP:0003179) | 3.04408777 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 2.93532746 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.93532746 |
| 24 | Premature rupture of membranes (HP:0001788) | 2.91698845 |
| 25 | Myocardial infarction (HP:0001658) | 2.89952575 |
| 26 | Peritonitis (HP:0002586) | 2.86966283 |
| 27 | Interstitial pulmonary disease (HP:0006530) | 2.85806281 |
| 28 | Loss of speech (HP:0002371) | 2.85239951 |
| 29 | Chronic obstructive pulmonary disease (HP:0006510) | 2.83257111 |
| 30 | Obstructive lung disease (HP:0006536) | 2.83257111 |
| 31 | T lymphocytopenia (HP:0005403) | 2.75373025 |
| 32 | Hyporeflexia of lower limbs (HP:0002600) | 2.74252730 |
| 33 | Abnormality of T cell number (HP:0011839) | 2.73639064 |
| 34 | Broad metatarsal (HP:0001783) | 2.70807265 |
| 35 | Encephalitis (HP:0002383) | 2.69718626 |
| 36 | Hematochezia (HP:0002573) | 2.68032577 |
| 37 | Increased connective tissue (HP:0009025) | 2.64289131 |
| 38 | Malnutrition (HP:0004395) | 2.62700582 |
| 39 | Increased cerebral lipofuscin (HP:0011813) | 2.58874960 |
| 40 | Atrophic scars (HP:0001075) | 2.55982565 |
| 41 | Episodic fever (HP:0001954) | 2.55797691 |
| 42 | Chest pain (HP:0100749) | 2.53752423 |
| 43 | Urticaria (HP:0001025) | 2.53557527 |
| 44 | Aortic aneurysm (HP:0004942) | 2.50844471 |
| 45 | Shallow orbits (HP:0000586) | 2.49798069 |
| 46 | Recurrent viral infections (HP:0004429) | 2.49737869 |
| 47 | Leukocytosis (HP:0001974) | 2.47035625 |
| 48 | Cervical subluxation (HP:0003308) | 2.45803153 |
| 49 | Pustule (HP:0200039) | 2.44074472 |
| 50 | Esophageal varix (HP:0002040) | 2.43033343 |
| 51 | Pulmonary embolism (HP:0002204) | 2.42802186 |
| 52 | Osteolytic defects of the hand bones (HP:0009699) | 2.39852398 |
| 53 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.39852398 |
| 54 | Axonal loss (HP:0003447) | 2.38629102 |
| 55 | Gangrene (HP:0100758) | 2.35639005 |
| 56 | Systemic lupus erythematosus (HP:0002725) | 2.34527052 |
| 57 | Autoimmune hemolytic anemia (HP:0001890) | 2.33796948 |
| 58 | Aneurysm (HP:0002617) | 2.33267079 |
| 59 | Prolonged bleeding time (HP:0003010) | 2.31366561 |
| 60 | Petechiae (HP:0000967) | 2.30888495 |
| 61 | Chronic diarrhea (HP:0002028) | 2.28983559 |
| 62 | Recurrent bronchitis (HP:0002837) | 2.27385024 |
| 63 | Abnormality of proline metabolism (HP:0010907) | 2.27289621 |
| 64 | Hydroxyprolinuria (HP:0003080) | 2.27289621 |
| 65 | Asymmetric septal hypertrophy (HP:0001670) | 2.27272089 |
| 66 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.27214824 |
| 67 | Aortic dissection (HP:0002647) | 2.26240855 |
| 68 | Exercise-induced muscle cramps (HP:0003710) | 2.25994160 |
| 69 | Polycythemia (HP:0001901) | 2.25776767 |
| 70 | Abnormality of the pleura (HP:0002103) | 2.25525366 |
| 71 | Deep venous thrombosis (HP:0002625) | 2.23406765 |
| 72 | Autoimmune thrombocytopenia (HP:0001973) | 2.23051218 |
| 73 | Osteomyelitis (HP:0002754) | 2.21864481 |
| 74 | Anorexia (HP:0002039) | 2.21235610 |
| 75 | Increased IgM level (HP:0003496) | 2.20847628 |
| 76 | Xanthomatosis (HP:0000991) | 2.20070153 |
| 77 | Gingival bleeding (HP:0000225) | 2.19477437 |
| 78 | Frequent falls (HP:0002359) | 2.18162064 |
| 79 | Mitral valve prolapse (HP:0001634) | 2.17617844 |
| 80 | Mucopolysacchariduria (HP:0008155) | 2.17507234 |
| 81 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.17507234 |
| 82 | Hypergammaglobulinemia (HP:0010702) | 2.16374441 |
| 83 | Recurrent abscess formation (HP:0002722) | 2.16131465 |
| 84 | Gastrointestinal stroma tumor (HP:0100723) | 2.15965438 |
| 85 | Ventricular tachycardia (HP:0004756) | 2.14552900 |
| 86 | Disinhibition (HP:0000734) | 2.14038261 |
| 87 | Joint swelling (HP:0001386) | 2.13817309 |
| 88 | Orchitis (HP:0100796) | 2.13106948 |
| 89 | Dysostosis multiplex (HP:0000943) | 2.12845531 |
| 90 | Muscle fiber splitting (HP:0003555) | 2.12642459 |
| 91 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.12000882 |
| 92 | Inflammation of the large intestine (HP:0002037) | 2.11610443 |
| 93 | Upper limb amyotrophy (HP:0009129) | 2.11060881 |
| 94 | Distal upper limb amyotrophy (HP:0007149) | 2.11060881 |
| 95 | Abnormality of T cells (HP:0002843) | 2.10700220 |
| 96 | Abnormality of the nasal mucosa (HP:0000433) | 2.08718721 |
| 97 | Nephritis (HP:0000123) | 2.08112432 |
| 98 | Polyneuropathy (HP:0001271) | 2.08097060 |
| 99 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.07825266 |
| 100 | Ankle contracture (HP:0006466) | 2.07471788 |
| 101 | Cellulitis (HP:0100658) | 2.07108021 |
| 102 | Increased density of long bones (HP:0006392) | 2.07071713 |
| 103 | Thin bony cortex (HP:0002753) | 2.06803797 |
| 104 | Epistaxis (HP:0000421) | 2.06498196 |
| 105 | Acne (HP:0001061) | 2.05983439 |
| 106 | Difficulty climbing stairs (HP:0003551) | 2.05811064 |
| 107 | Premature loss of primary teeth (HP:0006323) | 2.05654029 |
| 108 | Vacuolated lymphocytes (HP:0001922) | 2.03750928 |
| 109 | Difficulty running (HP:0009046) | 2.01770464 |
| 110 | Restrictive lung disease (HP:0002091) | 2.01718648 |
| 111 | Tetraparesis (HP:0002273) | 2.01006374 |
| 112 | Dilatation of the ascending aorta (HP:0005111) | 2.00722587 |
| 113 | Purpura (HP:0000979) | 2.00368848 |
| 114 | Myositis (HP:0100614) | 1.99645071 |
| 115 | Complement deficiency (HP:0004431) | 1.98326299 |
| 116 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.98013885 |
| 117 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.98013885 |
| 118 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.98013885 |
| 119 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.97859286 |
| 120 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.97349543 |
| 121 | Flat acetabular roof (HP:0003180) | 1.96458724 |
| 122 | Recurrent bacterial skin infections (HP:0005406) | 1.95750210 |
| 123 | Thick nail (HP:0001805) | 1.95396743 |
| 124 | Alopecia of scalp (HP:0002293) | 1.94667297 |
| 125 | Gastrointestinal inflammation (HP:0004386) | 1.94028380 |
| 126 | Granulocytopenia (HP:0001913) | 1.93310291 |
| 127 | Vertigo (HP:0002321) | 1.92668348 |
| 128 | Abnormality of macrophages (HP:0004311) | 1.92625239 |
| 129 | Eosinophilia (HP:0001880) | 1.91162765 |
| 130 | Increased serum ferritin (HP:0003281) | 1.91125634 |
| 131 | Basal ganglia calcification (HP:0002135) | 1.88251127 |
| 132 | Hand muscle atrophy (HP:0009130) | 1.86899181 |
| 133 | Mitral stenosis (HP:0001718) | 1.86358630 |
| 134 | Lymphopenia (HP:0001888) | 1.85746861 |
| 135 | Keratitis (HP:0000491) | 1.85464899 |
| 136 | Arthralgia (HP:0002829) | 1.84654778 |
| 137 | Progressive neurologic deterioration (HP:0002344) | 1.84532510 |
| 138 | Colitis (HP:0002583) | 1.84041183 |
| 139 | Nasal polyposis (HP:0100582) | 1.83622884 |
| 140 | Mutism (HP:0002300) | 1.82782238 |
| 141 | Ulnar bowing (HP:0003031) | 1.82074115 |
| 142 | Fragile skin (HP:0001030) | 1.81581181 |
| 143 | Arterial thrombosis (HP:0004420) | 1.80200849 |
| 144 | Increased IgE level (HP:0003212) | 1.80016335 |
| 145 | Abnormality of the pericardium (HP:0001697) | 1.79881984 |
| 146 | Vertebral compression fractures (HP:0002953) | 1.79811253 |
| 147 | Sudden death (HP:0001699) | 1.79589915 |
| 148 | Increased CSF protein (HP:0002922) | 1.79219791 |
| 149 | Gingivitis (HP:0000230) | 1.78613695 |
| 150 | Persistence of primary teeth (HP:0006335) | 1.76898413 |
| 151 | Hemorrhage of the eye (HP:0011885) | 1.75093752 |
| 152 | Periodontitis (HP:0000704) | 1.74802175 |
| 153 | Abnormality of the Achilles tendon (HP:0005109) | 1.74061672 |
| 154 | Type 1 muscle fiber predominance (HP:0003803) | 1.73549479 |
| 155 | Abnormality of complement system (HP:0005339) | 1.72616765 |
| 156 | Milia (HP:0001056) | 1.71328354 |
| 157 | Achilles tendon contracture (HP:0001771) | 1.67839984 |
| 158 | Striae distensae (HP:0001065) | 1.67560791 |
| 159 | Lymphangioma (HP:0100764) | 1.67475261 |
| 160 | Spontaneous hematomas (HP:0007420) | 1.66368449 |
| 161 | Disproportionate tall stature (HP:0001519) | 1.65287894 |
| 162 | Ulnar deviation of the wrist (HP:0003049) | 1.64285037 |
| 163 | Distal lower limb muscle weakness (HP:0009053) | 1.63981505 |
| 164 | Amyloidosis (HP:0011034) | 1.63115062 |
| 165 | Glomerulonephritis (HP:0000099) | 1.62054563 |
| 166 | Distal lower limb amyotrophy (HP:0008944) | 1.61164046 |
| 167 | Long toe (HP:0010511) | 1.60419246 |
| 168 | Arterial tortuosity (HP:0005116) | 1.60278704 |
| 169 | Genu recurvatum (HP:0002816) | 1.59049257 |
| 170 | Skin nodule (HP:0200036) | 1.59022346 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.59921519 |
| 2 | TRIB3 | 3.50368936 |
| 3 | TTN | 3.01411740 |
| 4 | EPHB1 | 2.53039107 |
| 5 | FGFR4 | 2.52536325 |
| 6 | PKN2 | 2.44558802 |
| 7 | IRAK4 | 2.42568051 |
| 8 | RIPK1 | 2.38254371 |
| 9 | PRPF4B | 2.25775062 |
| 10 | TYK2 | 1.97301236 |
| 11 | TGFBR2 | 1.97069722 |
| 12 | PTK6 | 1.96958453 |
| 13 | SIK1 | 1.91618855 |
| 14 | TBK1 | 1.90039590 |
| 15 | CDK12 | 1.76175485 |
| 16 | EPHA3 | 1.75080110 |
| 17 | FES | 1.74526891 |
| 18 | JAK1 | 1.72229829 |
| 19 | MAP3K14 | 1.68399308 |
| 20 | STK10 | 1.62242898 |
| 21 | MAP4K1 | 1.59691757 |
| 22 | LRRK2 | 1.58586097 |
| 23 | LATS1 | 1.57758107 |
| 24 | BMPR2 | 1.56657159 |
| 25 | EPHA2 | 1.54868060 |
| 26 | PDGFRA | 1.52481243 |
| 27 | IRAK1 | 1.45486753 |
| 28 | FGFR3 | 1.43668398 |
| 29 | FGR | 1.41356491 |
| 30 | MAP3K10 | 1.39952002 |
| 31 | TNK2 | 1.37736378 |
| 32 | DMPK | 1.35056652 |
| 33 | SIK3 | 1.34238097 |
| 34 | SYK | 1.33761186 |
| 35 | BMX | 1.33082042 |
| 36 | GRK7 | 1.31424860 |
| 37 | MAP3K3 | 1.29206110 |
| 38 | BTK | 1.27874830 |
| 39 | CSK | 1.26957463 |
| 40 | CDC42BPA | 1.26865279 |
| 41 | FRK | 1.25390483 |
| 42 | NEK9 | 1.22999879 |
| 43 | JAK3 | 1.22094435 |
| 44 | LYN | 1.19564779 |
| 45 | PTK2 | 1.15282044 |
| 46 | CAMK1D | 1.14218485 |
| 47 | IKBKE | 1.12684596 |
| 48 | MAP2K3 | 1.12379418 |
| 49 | JAK2 | 1.08557226 |
| 50 | ZAP70 | 1.07249115 |
| 51 | EEF2K | 1.04756538 |
| 52 | MAP3K11 | 1.03076098 |
| 53 | CHUK | 1.02326309 |
| 54 | FER | 1.01790779 |
| 55 | TAOK2 | 1.01580958 |
| 56 | MAP3K7 | 0.99455648 |
| 57 | DDR2 | 0.97331985 |
| 58 | NLK | 0.96019145 |
| 59 | PDGFRB | 0.95778570 |
| 60 | RIPK4 | 0.94578161 |
| 61 | CDK6 | 0.91237567 |
| 62 | IKBKB | 0.89605142 |
| 63 | HIPK2 | 0.89096330 |
| 64 | CAMK1G | 0.88875815 |
| 65 | PAK4 | 0.88834327 |
| 66 | IRAK2 | 0.88535518 |
| 67 | HCK | 0.88504578 |
| 68 | ITK | 0.87552299 |
| 69 | MATK | 0.86061088 |
| 70 | STK24 | 0.84350769 |
| 71 | TRPM7 | 0.83656428 |
| 72 | KIT | 0.83333930 |
| 73 | RET | 0.82582960 |
| 74 | LMTK2 | 0.81776362 |
| 75 | STK3 | 0.81671517 |
| 76 | TEC | 0.80513389 |
| 77 | BLK | 0.79823025 |
| 78 | YES1 | 0.77871499 |
| 79 | EPHB2 | 0.77383555 |
| 80 | PDK1 | 0.77131857 |
| 81 | IRAK3 | 0.76991665 |
| 82 | KSR2 | 0.73115659 |
| 83 | MTOR | 0.72021010 |
| 84 | DYRK1B | 0.70170797 |
| 85 | DAPK2 | 0.69357607 |
| 86 | MAPK7 | 0.68777977 |
| 87 | GRK6 | 0.68483217 |
| 88 | PRKCH | 0.67044769 |
| 89 | TAOK3 | 0.67000829 |
| 90 | MAP3K2 | 0.65425618 |
| 91 | ACVR1B | 0.64857646 |
| 92 | PRKD2 | 0.64322715 |
| 93 | MAP3K1 | 0.63763047 |
| 94 | MARK2 | 0.61899656 |
| 95 | RPS6KA4 | 0.59947780 |
| 96 | PRKCQ | 0.59588604 |
| 97 | MAPKAPK3 | 0.59425349 |
| 98 | PAK2 | 0.59222445 |
| 99 | ADRBK2 | 0.59079138 |
| 100 | TAOK1 | 0.58068817 |
| 101 | EGFR | 0.57203288 |
| 102 | MARK3 | 0.57160400 |
| 103 | PRKD1 | 0.56514785 |
| 104 | TYRO3 | 0.56115068 |
| 105 | GSK3A | 0.55816582 |
| 106 | MAPK12 | 0.55411469 |
| 107 | PAK3 | 0.55257941 |
| 108 | ALK | 0.54805318 |
| 109 | MAP3K13 | 0.54780493 |
| 110 | SGK2 | 0.54749744 |
| 111 | MST4 | 0.54069309 |
| 112 | PIM1 | 0.52158601 |
| 113 | MAP2K6 | 0.50568812 |
| 114 | INSRR | 0.49997048 |
| 115 | PRKAA2 | 0.48998675 |
| 116 | PIM2 | 0.48894562 |
| 117 | PIK3CG | 0.48552024 |
| 118 | MOS | 0.46937598 |
| 119 | PRKG2 | 0.46491427 |
| 120 | ABL1 | 0.46445038 |
| 121 | MST1R | 0.46129535 |
| 122 | MAP3K5 | 0.46015494 |
| 123 | SGK3 | 0.45533251 |
| 124 | CSF1R | 0.44071770 |
| 125 | LCK | 0.43406233 |
| 126 | MAP2K1 | 0.43390123 |
| 127 | FYN | 0.41867620 |
| 128 | FGFR1 | 0.41237079 |
| 129 | PDPK1 | 0.40399433 |
| 130 | MAPK11 | 0.40183598 |
| 131 | STK38 | 0.39763589 |
| 132 | PIK3CA | 0.39478934 |
| 133 | FLT3 | 0.39315771 |
| 134 | PTK2B | 0.38802879 |
| 135 | TXK | 0.38189496 |
| 136 | INSR | 0.37347494 |
| 137 | MAP2K2 | 0.37030011 |
| 138 | ERBB2 | 0.36860334 |
| 139 | CAMKK2 | 0.35450067 |
| 140 | MAPKAPK2 | 0.33709669 |
| 141 | STK11 | 0.29063189 |
| 142 | SIK2 | 0.27422489 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 2.52784868 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.45037660 |
| 3 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.24655840 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.20999090 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.04102358 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 1.97083884 |
| 7 | Asthma_Homo sapiens_hsa05310 | 1.88780163 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.73737192 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.62649518 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.61523370 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.56024856 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.53228929 |
| 13 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.51386810 |
| 14 | Malaria_Homo sapiens_hsa05144 | 1.51145195 |
| 15 | Amoebiasis_Homo sapiens_hsa05146 | 1.47301725 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.38791959 |
| 17 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.36364411 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.33884283 |
| 19 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33319212 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.30234325 |
| 21 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.29762540 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.28048105 |
| 23 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27667158 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.26964223 |
| 25 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.26227496 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23730421 |
| 27 | Focal adhesion_Homo sapiens_hsa04510 | 1.23584519 |
| 28 | Insulin resistance_Homo sapiens_hsa04931 | 1.22659403 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.20683031 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.18097588 |
| 31 | Adherens junction_Homo sapiens_hsa04520 | 1.18096246 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 1.17841084 |
| 33 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.17257757 |
| 34 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.17010755 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.16787424 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.16468262 |
| 37 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.16201185 |
| 38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.14991894 |
| 39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.14310308 |
| 40 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.13930099 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.11338565 |
| 42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.04587044 |
| 43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03924595 |
| 44 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.03646967 |
| 45 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.01130724 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99445166 |
| 47 | Salmonella infection_Homo sapiens_hsa05132 | 0.98010894 |
| 48 | Measles_Homo sapiens_hsa05162 | 0.97502435 |
| 49 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.96110576 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.94234545 |
| 51 | Bile secretion_Homo sapiens_hsa04976 | 0.94095431 |
| 52 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.92757602 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.91585195 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91379217 |
| 55 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.90833900 |
| 56 | Influenza A_Homo sapiens_hsa05164 | 0.90029308 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.89869177 |
| 58 | Bladder cancer_Homo sapiens_hsa05219 | 0.89219314 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 0.87428501 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87171783 |
| 61 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.83904904 |
| 62 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.81425719 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.81154909 |
| 64 | Shigellosis_Homo sapiens_hsa05131 | 0.80392632 |
| 65 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.80309904 |
| 66 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.80263643 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79963833 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79831459 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77958241 |
| 70 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.77184786 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76688456 |
| 72 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.76011327 |
| 73 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.75830348 |
| 74 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.75568524 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.74181026 |
| 76 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.72884097 |
| 77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71703873 |
| 78 | Hepatitis B_Homo sapiens_hsa05161 | 0.71348624 |
| 79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70080161 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69315468 |
| 81 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.68742146 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67772686 |
| 83 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.67477125 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67425079 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.67025010 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.66949488 |
| 87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66850068 |
| 88 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65894611 |
| 89 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65478427 |
| 90 | Phagosome_Homo sapiens_hsa04145 | 0.64520766 |
| 91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.64218061 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62927656 |
| 93 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62449577 |
| 94 | ABC transporters_Homo sapiens_hsa02010 | 0.62342761 |
| 95 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.62167033 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.61772268 |
| 97 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60565479 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60467563 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.60229898 |
| 100 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.59571966 |
| 101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59308337 |
| 102 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59267389 |
| 103 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.58600597 |
| 104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58526730 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56835388 |
| 106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56800977 |
| 107 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.56582099 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56264801 |
| 109 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55899820 |
| 110 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54960491 |
| 111 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54378441 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54169226 |
| 113 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54065501 |
| 114 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.52040359 |
| 115 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.51999968 |
| 116 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51668410 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49201559 |
| 118 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49127259 |
| 119 | Endocytosis_Homo sapiens_hsa04144 | 0.48227440 |
| 120 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.45410120 |
| 121 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44285863 |
| 122 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42749607 |
| 123 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42357736 |
| 124 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.42236277 |
| 125 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35188909 |
| 126 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31201433 |
| 127 | Prostate cancer_Homo sapiens_hsa05215 | 0.31120160 |
| 128 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31008633 |
| 129 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30921917 |
| 130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.30623769 |
| 131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.30502468 |
| 132 | Endometrial cancer_Homo sapiens_hsa05213 | 0.26951105 |

